A federal change in marijuana policy has states paying attention, and staying careful. Most leaders are not rushing to rewrite their laws. Still, one state stands out because of an old statute sitting on the books.
That state is South Carolina.
On Thursday, the U.S. Justice Department issued a final order that moved medical marijuana into Schedule III under federal drug law. The move followed a December directive from President Donald Trump. One key question popped up right away in places that still ban marijuana sales.
Did this federal rescheduling flip medical marijuana on in South Carolina by accident?
Not so fast. Federal scheduling and state legalization live in different lanes. Yet the federal shift creates real pressure points for states that have automatic “match the federal list” rules, or older medical research laws that never fully went away.
Tennessee moved first, and it moved to keep the door shut
Tennessee gave a clear example of how some states plan to respond.
As the federal government recognized cannabis as a medical drug under Schedule III, Tennessee’s leadership acted the same day to stop any automatic alignment. Republican Gov. Bill Lee signed a bill designed to block a built-in process that normally triggers a review when Washington changes a drug’s schedule.
In plain terms, Tennessee showed up ready to keep its ban in place.
A Tennessee senator, London Lamar, summed up the surprise in a comment to Nashville TV station WKRN. She said it felt like Tennessee was behind Trump on this issue.
That is not a sentence many people expected to hear in 2026.
States moved faster on hemp THC than on marijuana scheduling
Here’s another detail that makes this moment feel odd.
Many states have moved quickly on hemp-derived THC in the last year. They banned products, tightened rules, or built new regulations. A new federal definition of hemp takes effect in November, and states have scrambled to match it.
Marijuana rescheduling has not produced that same sprint.
This federal shift raises bigger questions that take time to sort out. Interstate sales rules come up fast. Research rules change. Pharmaceutical pathways matter. State regulators and governors seem to want answers before they redraw their entire playbook.
So you see a lot of careful statements and very few bold moves.
South Carolina’s twist is a law from 1980 that still carries weight
South Carolina has no full adult-use program. It also has not passed a modern medical cannabis program, even after years of debate.
Yet South Carolina has something many people forgot exists.
The state has a decades-old statute called the Controlled Substances Therapeutic Research Act of 1980. Reports out of Charleston point to that law as a reason federal rescheduling creates special pressure in South Carolina.
The 1980 law gives state regulators authority to oversee marijuana through a therapeutic research style program. The text describes distribution to certain patient groups, including people dealing with cancer treatment side effects and people diagnosed with glaucoma. The law also directs the health agency to write regulations and to look at federal agency rules as part of that work.
That is not the same thing as a modern medical marijuana market with dispensaries, broad qualifying conditions, and a full license system.
Still, it is not nothing. It is a legal hook that state leaders have to think about once federal policy shifts.
Health regulators are taking it slow
Even with the old statute sitting there, South Carolina health officials have not rushed out a new program.
State health leadership has acknowledged the federal rescheduling move and said it is reviewing what the change means for the agency and for South Carolina. That kind of statement signals review, not rollout.
If you run cannabis operations in other states, you’ve seen this movie. Agencies do not change direction overnight. They review, consult, and wait for guidance, then they move.
Lawmakers in South Carolina have tried, and failed, to pass medical cannabis bills
Separate from the 1980 research law, South Carolina lawmakers have debated full medical cannabis legislation again and again. Those bills have not crossed the finish line.
Reports from inside the State House say the political energy looks low this year. One familiar name in the South Carolina medical cannabis debate, state Sen. Tom Davis, did not file a new draft bill this session.
Timing also works against big changes. With fewer than 7 days left in the legislative calendar at the time of reporting, lawmakers have little runway for a major policy shift. Medical cannabis bills are long. They come with licensing rules, enforcement rules, testing rules, and agency assignments. That is not a one-afternoon vote.
Does federal rescheduling change state cannabis law?
For operators, this is the practical point.
Federal rescheduling does not rewrite state laws by itself. States still decide what is legal inside their borders, what licenses exist, and what enforcement looks like.
Around the country, regulators have told license holders to keep operating under current state rules. California’s cannabis regulators said they are reviewing the federal order. That statement signals analysis, not immediate changes for businesses already licensed under state law.
So if you operate in a state market, your compliance checklist stays tied to your state program until your state says otherwise.
The real risk is confusion, not clarity
Federal scheduling changes create headlines. Headlines create phone calls. Phone calls turn into rumors. Rumors spread faster than rulemaking.
In states like South Carolina, that confusion hits extra hard because the legal framework is uneven. There is an old research statute. There is no modern commercial medical program. There is also political gridlock that has stopped new medical bills in past sessions.
That mix leads to one big takeaway.
South Carolina is not “fully medical” just because Washington moved medical marijuana to Schedule III. The federal change adds pressure and raises new questions. It does not build a state program on its own.
If you want to track what happens next, watch two things.
First, any public steps by South Carolina’s health agency tied to that 1980 law.
Second, whether lawmakers pick up medical cannabis again in the next session, with enough calendar time to pass a real bill.